Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Gunapala · SciRah

Researcher profile · Semantic Scholar

R. Gunapala

Share profile

R. Gunapala — researcher profile on SciRah

h-index: 12
Works: 35
Citations: 436

Most-cited papers

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya, E. Killick, Sarah Thomas, N. Taylor +28 more
2017Familial Cancer66 citations Open access
Semantic Scholar
Standard and hypofractionated dose escalation to intraprostatic tumour nodules in localised prostate cancer: efficacy and toxicity in the DELINEATE trial.
J. Murray, A. Tree, E. Alexander, A. Sohaib +11 more
2019International Journal of Radiation Oncology, Biology, Physics51 citations Open access
Semantic Scholar
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma.
A. Minchom, R. Punwani, Jacqueline Filshie, J. Bhosle +5 more
2016European Journal of Cancer45 citations
Semantic Scholar
Resolution of severe hyponatraemia is associated with improved survival in patients with cancer
K. Balachandran, A. Okines, R. Gunapala, D. Morganstein +1 more
2015BMC Cancer34 citations Open access
Semantic Scholar
Diethylstilbestrol in castration‐resistant prostate cancer
A. Wilkins, M. Shahidi, C. Parker, R. Gunapala +4 more
2012BJU International33 citations
Semantic Scholar
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy
Gillian Adair-Smith, A. Dunlop, S. Alexander, H. Barnes +18 more
2023Radiotherapy and Oncology31 citations Open access
Semantic Scholar
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
M. Linch, S. Gennatas, Stanislav Kazikin, J. Iqbal +8 more
2014BMC Cancer30 citations Open access
Semantic Scholar
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer.
W. Cui, C. Milner-Watts, T. McVeigh, A. Minchom +10 more
2022Lung Cancer28 citations
Semantic Scholar
A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks.
M. O'Brien, J. Myerson, J. Coward, M. Puglisi +8 more
2012European Journal of Cancer27 citations
Semantic Scholar
Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres
S. Gennatas, J. Noble, Susannah Stanway, R. Gunapala +4 more
2015BMJ Open19 citations Open access
Semantic Scholar
Spect perfusion imaging versus CT for predicting radiation injury to normal lung in lung cancer patients
Alex Weller, A. Dunlop, Adam Oxer, R. Gunapala +5 more
2019British Journal of Radiology15 citations Open access
Semantic Scholar
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
Rajiv Kumar, S. Lu, A. Minchom, A. Sharp +6 more
2016Cancer Chemotherapy and Pharmacology15 citations
Semantic Scholar
Patient factors, health care factors and survival from lung cancer according to ethnic group in the south of London, UK.
K. Nimako, R. Gunapala, S. Popat, M. O'Brien
2013European Journal of Cancer Care11 citations Open access
Semantic Scholar
A Pilot Study of a Novel Home Telemonitoring System for Oncology Patients Receiving Chemotherapy
K. Nimako, S. Lu, B. Ayite, K. Priest +4 more
2013Journal of Telemedicine and Telecare10 citations
Semantic Scholar
A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic
K. Nimako, B. Ayite, K. Priest, J. Severn +5 more
2017European Journal of Cancer Care8 citations Open access
Semantic Scholar
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI
Gillian Adair-Smith, A. Dunlop, S. Alexander, H. Barnes +17 more
2022Technical Innovations & Patient Support in Radiation Oncology7 citations Open access
Semantic Scholar
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
A. Minchom, D. Mak, R. Gunapala, D. Walder +6 more
2019PLoS ONE2 citations Open access
Semantic Scholar
Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC.
Rajiv Kumar, D. Walder, A. Pejanaute, R. Gunapala +11 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
P3.05-006 Anxiolytic Effect of Acupuncture in a Phase II Study of Acupuncture and Morphine for Dyspnea in Lung Cancer and Mesothelioma: Topic: Symptoms, Therapeutic Interventions
A. Minchom, R. Punwani, J. Filshie, J. Bhosle +5 more
20171 citations Open access
Semantic Scholar
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
M. Linch, S. Gennatas, Stanislav Kazikin, J. Iqbal +8 more
2014BMC Cancer1 citations Open access
Semantic Scholar
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
A. Minchom, K. Saksornchai, J. Bhosle, R. Gunapala +8 more
2014BMJ Open Respiratory Research1 citations Open access
Semantic Scholar
33 Outcomes of patients undergoing adjuvant platinum–vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
A. Pender, J. Coward, R. Gunapala, J. Bhosle +2 more
20131 citations
Semantic Scholar
P1.01-79 G8 Screening Scores in Elderly Advanced Lung Cancer Patients: A Prospective Single Institution Study
X. Wu, U. Janžič, C. Milner-Watts, D. Walder +5 more
2019Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Journal Pre-proof Standard and hypofractionated dose escalation to intraprostatic tumour nodules in localised prostate cancer: efficacy and toxicity in the DELINEATE trial
J. Murray, A. Tree, E. Alexander, Aslam +13 more
20190 citations
Semantic Scholar
Less frequent monitoring of response in patients with advanced thoracic malignancies receiving palliative chemotherapy, does not adversely impact patient care
C. Milner-Watts, Rajiv Kumar, R. Gunapala, D. Walder +5 more
20180 citations
Semantic Scholar
The impact of the UK Government ‘two week rule’ (TWR) on lung cancer stage and 5-year survival – a decade of experience from the Royal Marsden Hospital (RMH)
S. Dolly, M. Brandao, C. Taylor, R. Gunapala +5 more
20180 citations
Semantic Scholar
P3.12-003 Optimized Inhaler Therapy Is Superior to Supportive Care Alone for Dyspnea in Patients with Coexisting COPD and Lung Cancer
D. Walder, Ravi Punwani, R. Gunapala, Rajiv Kumar +5 more
20170 citations Open access
Semantic Scholar
P1.03-029 Study of Plasma Homocysteine as a Marker of Toxicity and Depression in Patients Treated with Pemetrexed-Based Chemotherapy
A. Minchom, R. Gunapala, D. Walder, Rajiv Kumar +4 more
20170 citations Open access
Semantic Scholar
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya, E. Killick, Sarah Thomas, N. Taylor +28 more
2017Familial Cancer0 citations Open access
Semantic Scholar
PUB129 Optimal Frequency of Tumor Response Evaluation during Palliative Chemotherapy in the Management of Patients with Advanced Thoracic Cancers
Rajiv Kumar, J. Bhosle, T. Yap, A. Minchom +7 more
20170 citations Open access
Semantic Scholar
69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme
N. Tokaca, M. Crawford, A. Greystoke, W. Appel +18 more
20170 citations
Semantic Scholar
163 A randomised study comparing the effectiveness of acupuncture (A) or morphine (M) versus the combination (AM) for the relief of dyspnoea in patients with advanced non small cell lung cancer and mesothelioma
A. Minchom, R. Punwani, J. Filshie, J. Bhosle +4 more
20160 citations
Semantic Scholar
An empirical study on determinants of talent shortage in the hotel industry in Sri Lanka
R. Gunapala
20140 citations
Semantic Scholar
38 Patterns of relapse and detection method in patients with resected non-small cell lung cancer (NSCLC) – a single institution experience
A. Pender, J. Coward, R. Gunapala, J. Bhosle +2 more
20140 citations
Semantic Scholar
76 The UK ‘two week rule’ for lung cancer – 5-year survival update
J. Myerson, M. O'Brien, T. Waddell, A. Reid +5 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Popat×20
Invite
S. Popat — researcher profile on SciRah
J. Bhosle×19
Invite
J. Bhosle — researcher profile on SciRah
M. O'Brien×17
Invite
M. O'Brien — researcher profile on SciRah
A. Minchom×12
Invite
A. Minchom — researcher profile on SciRah

×8

Invite

K. Nimako — researcher profile on SciRah

Invite

Rajiv Kumar — researcher profile on SciRah

Invite

D. Walder — researcher profile on SciRah

Invite

J. Myerson — researcher profile on SciRah

Nadia Yousaf×5

Invite

Nadia Yousaf — researcher profile on SciRah

Invite

R. Huddart — researcher profile on SciRah

Invite

S. Popat — researcher profile on SciRah

Invite

M. O'Brien — researcher profile on SciRah